直击in vivo CAR-T痛点:HCP控制的工程化解法 2026/06/17[dsm_breadcrumbs home_text="首页" show_home_icon="off"... read more
临床数据公布!解读in vivo TCE技术优势与最新进展 2026/06/15[dsm_breadcrumbs home_text="首页" show_home_icon="off"... read more
不止血液治疗!一文解读造血干细胞(HSC)应用进展 2026/06/09[dsm_breadcrumbs home_text="首页" show_home_icon="off"... read more
in vivo CAR-T的下一场产业化竞赛:慢病毒路径仍然重要 2026/05/25[dsm_breadcrumbs home_text="首页" show_home_icon="off"... read more
寡核苷酸酶法合成技术全景解析:传统与创新的协同进化 2026/04/20[dsm_breadcrumbs home_text="首页" show_home_icon="off"... read more
从“一只狗”的肿瘤疫苗,看个体化mRNA癌症疫苗(PCV)真正的落地路径 2026/04/08[dsm_breadcrumbs home_text="首页" show_home_icon="off"... read more
2025“爆发元年”:in-vivo CAR-T里程碑汇总! 2026/02/02[dsm_breadcrumbs home_text="首页" show_home_icon="off"... read more